Form 8-K · Current Report · Filed 2024-02-27
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
Agilent Technologies, Inc. reported financial results for the first fiscal quarter of 2024. The company's revenue of $1.66 billion showed a 5.6% decline year-over-year. GAAP net income was $348 million with earnings per share (EPS) of $1.18, down 1% from the first quarter of 2023. Non-GAAP net income was $380 million with EPS of $1.29, down 6% from the previous year. The company maintained its full-year revenue outlook at $6.710 billion to $6.810 billion, with non-GAAP earnings guidance of $5.44 to $5.55 per share. Agilent's Life Sciences and Applied Markets Group and Diagnostics and Genomics Group reported declines in revenue, while the Agilent CrossLab Group saw an increase. The company also provided guidance for the second quarter with expected revenue between $1.560 billion and $1.590 billion and non-GAAP EPS between $1.17 and $1.20.
- Filer
- Agilent Technologies Inc. A · NYSE
- Filed
- Accession
- 0001090872-24-000006
- CIK
- 0001090872
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$131.49
Next session
+4.2%
Since filing
+5.2%
Latest close
$138.37
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from A reporting the same item, with the next session's move:
Exhibits (1)
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Never miss another A filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.